This study introduces the method of establishing A2 B5+/CD133– glioma stem cell line to serve as a foundation for the basic research and clinical trial of targeted therapy against glioma stem like cells. Isolated from the specimens obtained from a male patient who suffered from glioma recurrence, the glioma cells were cultured for 10 generations(SHG-140), after which the A2 B5+/CD133– subgroup cells were separated and cloned to another cell line(SHG-ZW) and further transferred to stem cell line(SHG-ZWs). Im...